Overview

ALACOVID Study for Vaccinated Subjects

Status:
Not yet recruiting
Trial end date:
2022-06-15
Target enrollment:
Participant gender:
Summary
In this study, it is hypothesized that administration of 5-ALA-Phosphate + SFC in subjects vaccinated against Covid-19 could contribute in enhancing the targeted function of the immune system, which might lead to re-activation and/or increase of the vaccination response. Thus, in the present study, we will be evaluating the safety and efficacy of 5-ALA-Phosphate + SFC in subjects receiving the Covid-19 vaccine.
Phase:
N/A
Details
Lead Sponsor:
Vedic Lifesciences Pvt. Ltd.